Rachele Bigi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Molecular mechanisms of naringenin modulation of mitochondrial permeability transition acting on F1FO-ATPase and counteracting saline load-induced injury in SHRSP cerebral endothelial cells	EUROPEAN JOURNAL OF CELL BIOLOGY	2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach	MULTIPLE SCLEROSIS	2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis	MICROORGANISMS	2024
FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk	BIOLOGY	2023
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome	SCIENTIFIC REPORTS	2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS	FRONTIERS IN NEUROLOGY	2022
Exosome-Encased Nucleic Acid Scaffold Chemotherapeutic Agents for Superior Anti-Tumor and Anti-Angiogenesis Activity	ACS BIO & MED CHEM AU	2022
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases	MICROORGANISMS	2021
A case of double standard. Sex differences in multiple sclerosis risk factors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?	FRONTIERS IN IMMUNOLOGY	2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies	EBIOMEDICINE	2021
Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association	bioRxiv	2021
Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis	GENES	2020
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets	F1000RESEARCH	2020
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA	2019
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma	MBIO	2019
Extracellular vesicles from Kaposi Sarcoma-associated herpesvirus lymphoma induce long-term endothelial cell reprogramming	PLOS PATHOGENS	2019
Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections	JOURNAL OF VIROLOGY	2018
Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA	2018
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation	JOURNAL OF ANTIBIOTICS	2017